Coxsackievirus-induced cardiomyopathy

Coxsackievirus-induced cardiomyopathy
Synonyms	Viral myocarditis
Pronounce	N/A
Specialty	N/A
Symptoms	Chest pain, fatigue, shortness of breath, arrhythmia
Complications	Heart failure, sudden cardiac death
Onset	Sudden or gradual
Duration	Variable
Types	N/A
Causes	Coxsackievirus infection
Risks	Immunosuppression, genetic predisposition
Diagnosis	Electrocardiogram, echocardiogram, cardiac MRI, endomyocardial biopsy
Differential diagnosis	Ischemic heart disease, dilated cardiomyopathy, pericarditis
Prevention	Hand hygiene, vaccination (experimental)
Treatment	Supportive care, antiviral therapy, immunosuppressive therapy
Medication	N/A
Prognosis	Variable; can be self-limiting or lead to chronic heart disease
Frequency	Rare
Deaths	N/A

- Coxsackieviruses-induced cardiomyopathy are positive-stranded RNA viruses in picornavirus family and the genus enterovirus, acute enterovirus infections such as Coxsackievirus B3 have been identified as the cause of virally induced acute myocarditis, resulting in dilated cardiomyopathy. Dilated cardiomyopathy in humans can be caused by multiple factors including hereditary defects in the cytoskeletal protein dystrophin in Duchenne muscular dystrophy (DMD) patients). A heart that undergoes dilated cardiomyopathy shows unique enlargement of ventricles, and thinning of the ventricular wall that may lead to heart failure. In addition to the genetic defects in dystrophin or other cytoskeletal proteins, a subset of dilated cardiomyopathy is linked to enteroviral infection in the heart, especiall [[Category:Uncategorized

This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.